Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes

• Main Authors: Holmdahl, I. (Author), Jernigan, J. (Author), Kahn, R. (Author), Mina, M.J (Author), Reddy, S. (Author), Slayton, R.B (Author)
• Format: Article
• Language: English
• Published: Oxford University Press 2022
• Subjects: ad26.cov2.s vaccine; Article; asymptomatic coronavirus disease 2019; coronavirus disease 2019; COVID-19; COVID-19 testing; human; Humans; immunity; janssen; nursing home; nursing home patient; nursing homes; Nursing Homes; nursing staff; prevention and control; SARS-CoV-2; SARS-CoV-2 vaccine; screening test; Skilled Nursing Facilities; stochastic model; susceptible exposed infectious recovered model; symptom; United States; vaccination; Vaccination; vaccination coverage; vaccine efficacy; virus transmission
• Online Access: View Fulltext in Publisher

 Nursing home residents and staff were included in the first phase of coronavirus disease 2019 vaccination in the United States. Because the primary trial endpoint was vaccine efficacy (VE) against symptomatic disease, there are limited data on the extent to which vaccines protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the ability to infect others (infectiousness). Assumptions about VE against infection and infectiousness have implications for changes to infection prevention guidance for vaccinated populations, including testing strategies. Methods: We use a stochastic agent-based Susceptible-Exposed-Infectious (Asymptomatic/Symptomatic)-Recovered model of a nursing home to simulate SARS-CoV-2 transmission. We model 3 scenarios, varying VE against infection, infectiousness, and symptoms, to understand the expected impact of vaccination in nursing homes, increasing staff vaccination coverage, and different screening testing strategies under each scenario. Results: Increasing vaccination coverage in staff decreases total symptomatic cases in the nursing home (among staff and residents combined) in each VE scenario. In scenarios with 50% and 90% VE against infection and infectiousness, increasing staff coverage reduces symptomatic cases among residents. If vaccination only protects against symptoms, and asymptomatic cases remain infectious, increased staff coverage increases symptomatic cases among residents. However, this is outweighed by the reduction in symptomatic cases among staff. Higher frequency testing - more than once weekly - is needed to reduce total symptomatic cases if the vaccine has lower efficacy against infection and infectiousness, or only protects against symptoms. Conclusions: Encouraging staff vaccination is not only important for protecting staff, but might also reduce symptomatic cases in residents if a vaccine confers at least some protection against infection or infectiousness. © 2021 Published by Oxford University Press for the Infectious Diseases Society of America 2021.